National Gnotobiotic Rodent Resource Center

国家知生啮齿动物资源中心

基本信息

  • 批准号:
    7925576
  • 负责人:
  • 金额:
    $ 53.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-30 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Environmental factors modify genetic susceptibility to many chronic diseases. Commensal microbiota profoundly influence physiologic responses in a number of organs and heavily contribute to inflammatory, neoplastic and possibly degenerative diseases. The NGRRC provides a resource for local, regional, national and international multidisciplinary investigators to explore the hypothesis that commensal bacteria fundamentally Influence normal physiologic processes in normal hosts and pathogenic inflammatory and neoplastic responses in genetically susceptible hosts. This unit provides a resource for broadly based investigators to examine physiologic and pathophysiologic differences in germ-free (sterile) vs. gnotobiotic (known life) vs. specific pathogen-free rodents of different genetic backgrounds, and to define the physiologic and pathophysiologic relevance of bacterial genes. The microbiota can be precisely manipulated by colonizing germ-free rodents with single or multiple commensal or pathogenic bacterial or fungal species, using isogenic wild type or genetically engineered bacterial strains. Specific aims: 1. Provide germ-free or selectively colonized wild type and mutant mice and rats or their tissues and cells to NIH-funded investigators. 2. Develop innovative techniques to efficiently derive germ-free breeding colonies of new strains of mice and rats for requesting investigators and for the molecular detection and identification of contaminating bacteria. 3. Support pilot studies for investigators with novel hypotheses to generate preliminary data for NIH grant applications. We provide a unique and essential resource for a large, diverse group of NIH-funded investigators to study the physiologic and pathophysiologic consequences of colonization by commensal bacteria, with particular emphasis on gene/environmental interactions in genetically altered mice (transgenic, knockout or spontaneously mutated) with altered physiology and disease phenotypes. In our initial 4 years of funding, the NGRRC has provided 4621 gnotobiotic mice and rats to 61 investigators in 35 institutions. 39 funded and 11 submitted grants by 32 investigators depend on gnotobiotic animals from the NGRRC. Unique features of our facility are 1) interaction with the UNC Mutant Mouse Regional Resource Center (MMRRC), 2) the experience of the applicant team, 3) innovation in embryo transfer and cryopreservation, 4) The option for onsite tissue collection by external investigators, 5) highly trained technical staff to collect tissues or isolate cells for requesting investigators. PUBLIC HEALTH RELEVANCE (provided by applicant): The NGRRC provides a local, regional, national and international resource for NIH-funded investigators to explore the role of commensal bacteria on normal physiologic and pathophysiologic processes in wild type and genetically engineered rodents and trains investigators and staff in other facilities in gnotobiotic technology. The research component of this application explores novel ways of deriving gnotobiotic mice and using molecular techniques to detect and identify contaminating organisms. In addition, it permits investigators to obtain preliminary data to submit competitive grant applications. In the past funding cycle these preliminary data and access to our facility resulted in 6 new funded grants.
描述(由申请人提供):环境因素会改变对许多慢性疾病的遗传易感性。共生微生物群深刻影响许多器官的生理反应,并在很大程度上导致炎症、肿瘤和可能的退行性疾病。 NGRRC 为地方、区域、国家和国际多学科研究人员提供了资源,以探索共生细菌从根本上影响正常宿主的正常生理过程以及遗传易感宿主的致病性炎症和肿瘤反应的假设。该单元为广泛的研究人员提供了资源,以检查无菌(无菌)与无菌(已知生命)与不同遗传背景的特定无病原体啮齿动物之间的生理和病理生理差异,并定义生理和病理生理相关性细菌基因。通过使用同基因野生型或基因工程细菌菌株,用单个或多个共生或致病细菌或真菌物种定殖无菌啮齿动物,可以精确地操纵微生物群。具体目标: 1. 向 NIH 资助的研究人员提供无菌或选择性定植的野生型和突变型小鼠和大鼠或其组织和细胞。 2. 开发创新技术,有效地获得新小鼠和大鼠品系的无菌繁殖群体,以供研究人员以及污染细菌的分子检测和鉴定。 3. 支持研究人员进行新假设的试点研究,为 NIH 拨款申请生成初步数据。我们为 NIH 资助的大型、多样化的研究人员提供了独特且重要的资源,以研究共生细菌定植的生理和病理生理后果,特别强调基因改变小鼠(转基因、敲除或自发突变)的基因/环境相互作用)具有改变的生理学和疾病表型。在最初 4 年的资助中,NGRRC 已向 35 个机构的 61 名研究人员提供了 4621 只无菌小鼠和大鼠。 32 名研究人员有 39 项资助和 11 项提交资助依赖于 NGRRC 的限生动物。我们设施的独特之处在于 1) 与北卡罗来纳大学突变小鼠区域资源中心 (MMRRC) 的互动,2) 申请团队的经验,3) 胚胎移植和冷冻保存方面的创新,4) 外部研究人员可以进行现场组织采集,5)训练有素的技术人员为有要求的研究者收集组织或分离细胞。 公共健康相关性(由申请人提供):NGRRC 为 NIH 资助的研究人员提供地方、区域、国家和国际资源,以探索共生细菌对野生型和基因工程啮齿动物正常生理和病理生理过程的作用,并培训研究人员和其他生殖技术设施的工作人员。该应用程序的研究部分探索了培育无菌小鼠并使用分子技术检测和识别污染生物体的新方法。此外,它还允许研究人员获得初步数据以提交竞争性资助申请。在过去的资助周期中,这些初步数据和对我们设施的访问导致了 6 项新的资助。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ryan B Sartor其他文献

Ryan B Sartor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ryan B Sartor', 18)}}的其他基金

Host innate immune-microbial interactions and intestinal inflammation
宿主先天免疫-微生物相互作用和肠道炎症
  • 批准号:
    8552303
  • 财政年份:
    2013
  • 资助金额:
    $ 53.41万
  • 项目类别:
Identifying Microbial, Epithelial and Immune Cell Interactions that Mediate Mucosal Homeostasis and Determine IBD Phenotypes
识别介导粘膜稳态并确定 IBD 表型的微生物、上皮细胞和免疫细胞相互作用
  • 批准号:
    10642786
  • 财政年份:
    2013
  • 资助金额:
    $ 53.41万
  • 项目类别:
Identifying Microbial, Epithelial and Immune Cell Interactions that Mediate Mucosal Homeostasis and Determine IBD Phenotype
识别介导粘膜稳态并确定 IBD 表型的微生物、上皮细胞和免疫细胞相互作用
  • 批准号:
    10616986
  • 财政年份:
    2013
  • 资助金额:
    $ 53.41万
  • 项目类别:
Induction of protective IL-10- producing B and T cells by defined subsets of resident intestinal bacteria
通过特定的肠道细菌亚群诱导产生保护性 IL-10 的 B 和 T 细胞
  • 批准号:
    10642799
  • 财政年份:
    2013
  • 资助金额:
    $ 53.41万
  • 项目类别:
Identifying Microbial, Epithelial and Immune Cell Interactions that Mediate Mucosal Homeostasis and Determine IBD Phenotypes
识别介导粘膜稳态并确定 IBD 表型的微生物、上皮细胞和免疫细胞相互作用
  • 批准号:
    10723727
  • 财政年份:
    2013
  • 资助金额:
    $ 53.41万
  • 项目类别:
Identifying Microbial, Epithelial and Immune Cell Interactions that Mediate Mucosal Homeostasis and Determine IBD Phenotypes
识别介导粘膜稳态并确定 IBD 表型的微生物、上皮细胞和免疫细胞相互作用
  • 批准号:
    10216236
  • 财政年份:
    2013
  • 资助金额:
    $ 53.41万
  • 项目类别:
Host innate immune-microbial interactions and intestinal inflammation
宿主先天免疫-微生物相互作用和肠道炎症
  • 批准号:
    8737236
  • 财政年份:
    2013
  • 资助金额:
    $ 53.41万
  • 项目类别:
Core A: Animal Models Core
核心 A:动物模型核心
  • 批准号:
    10447739
  • 财政年份:
    2013
  • 资助金额:
    $ 53.41万
  • 项目类别:
Identifying Microbial, Epithelial and Immune Cell Interactions that Mediate Mucosal Homeostasis and Determine IBD Phenotypes
识别介导粘膜稳态并确定 IBD 表型的微生物、上皮细胞和免疫细胞相互作用
  • 批准号:
    10447738
  • 财政年份:
    2013
  • 资助金额:
    $ 53.41万
  • 项目类别:
Identifying Microbial, Epithelial and Immune Cell Interactions that Mediate Mucosal Homeostasis and Determine IBD Phenotypes
识别介导粘膜稳态并确定 IBD 表型的微生物、上皮细胞和免疫细胞相互作用
  • 批准号:
    10018853
  • 财政年份:
    2013
  • 资助金额:
    $ 53.41万
  • 项目类别:

相似海外基金

Mechanisms of Nanomaterials-based Combination Adjuvants
纳米材料复合佐剂的作用机制
  • 批准号:
    10586948
  • 财政年份:
    2022
  • 资助金额:
    $ 53.41万
  • 项目类别:
Host proteins that interact with the BCG cell envelope
与 BCG 细胞包膜相互作用的宿主蛋白
  • 批准号:
    10408860
  • 财政年份:
    2021
  • 资助金额:
    $ 53.41万
  • 项目类别:
Host proteins that interact with the BCG cell envelope
与 BCG 细胞包膜相互作用的宿主蛋白
  • 批准号:
    10288316
  • 财政年份:
    2021
  • 资助金额:
    $ 53.41万
  • 项目类别:
FcRn-targeted mucosal HIV vaccine
FcRn 靶向粘膜 HIV 疫苗
  • 批准号:
    8513912
  • 财政年份:
    2012
  • 资助金额:
    $ 53.41万
  • 项目类别:
FcRn-targeted mucosal HIV vaccine
FcRn 靶向粘膜 HIV 疫苗
  • 批准号:
    8685882
  • 财政年份:
    2012
  • 资助金额:
    $ 53.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了